In a line with our ezrin Thr567 phosphorylation inhibition results, celastrol inhibits the phosphorylation of ROCK2, and therefore perturbs its kinase activity in hepatocellular carcinoma cells (Fig. 4E). Here, EZR is linked to hepatocellular carcinoma.